Furthermore, decreasing the level of CLDN3 and CLDN4 proteins through knockdown of CLDN3 and CLDN4 in prostate cancer resulted in a 30–40% decrease in prostate cancer cell growth, a 60–65% reduction in cell viability, and cell migration [209]. The gene discussed is CLDN3; the disease is prostate carcinoma.